Product Description: LSD1-IN-20 (compound 1) is a potent dual non-covalent LSD1/G9a inhibitor, with Ki values of 0.44 and 0.68 μM, respectively. LSD1-IN-20 shows antiproliferative activity in THP-1 leukemia cells and MDA-MB-231 breast cancer cells, with IC50 (72 h) of 0.51 and 1.60 μM, respectively[1].
Applications: Cancer-programmed cell death
Formula: C27H38N6O2
References: [1]Menna M, et al. Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models. Eur J Med Chem. 2022 Jul 5;237:114410.
CAS Number: 1239589-91-3
Molecular Weight: 478.63
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Histone Demethylase;Histone Methyltransferase